Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $1,000 | 1 | 93.2% |
| Food and Beverage | $73.16 | 5 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bard Access Systems, Inc. | $1,000 | 1 | $0 (2020) |
| Apyx Medical Corporation | $36.00 | 2 | $0 (2019) |
| AbbVie Inc. | $14.51 | 1 | $0 (2023) |
| Merz North America, Inc. | $11.55 | 1 | $0 (2019) |
| Galderma Laboratories, L.P. | $11.10 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.51 | 1 | AbbVie Inc. ($14.51) |
| 2020 | $1,000 | 1 | Bard Access Systems, Inc. ($1,000) |
| 2019 | $58.65 | 4 | Apyx Medical Corporation ($36.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2020 | Bard Access Systems, Inc. | — | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| 08/19/2019 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.10 | General |
| 03/18/2019 | Apyx Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $9.08 | General |
| 03/04/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $11.55 | General |
| Category: DERMATOLOGY | ||||||
| 01/26/2019 | Apyx Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $26.92 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 220 | 373 | $53,075 | $14,688 |
| 2022 | 6 | 216 | 389 | $48,187 | $14,862 |
| 2021 | 9 | 320 | 594 | $81,282 | $25,603 |
| 2020 | 9 | 317 | 544 | $72,455 | $20,416 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 69 | $16,207 | $5,403 | 33.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 32 | 36 | $8,671 | $2,877 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $4,923 | $1,898 | 38.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 42 | 46 | $8,159 | $1,495 | 18.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 18 | 25 | $7,700 | $1,326 | 17.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 12 | $4,632 | $946.99 | 20.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 32 | 155 | $2,782 | $740.48 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 62 | $13,712 | $5,279 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 58 | $8,898 | $3,578 | 40.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 34 | 35 | $8,430 | $2,402 | 28.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 37 | 43 | $7,627 | $1,488 | 19.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 16 | 21 | $6,468 | $1,267 | 19.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 28 | 170 | $3,052 | $848.69 | 27.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 75 | $16,275 | $6,506 | 40.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 77 | $11,579 | $4,926 | 42.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 39 | 43 | $10,357 | $3,530 | 34.1% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 19 | 27 | $10,421 | $3,065 | 29.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 52 | 63 | $11,174 | $2,084 | 18.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 24 | 27 | $8,316 | $1,786 | 21.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $4,699 | $1,361 | 29.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 40 | 247 | $4,434 | $1,195 | 27.0% |
| 17111 | Destruction of 15 or more non-cancerous skin growths | Office | 2021 | 11 | 14 | $4,027 | $1,151 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 73 | $15,841 | $5,761 | 36.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 83 | $12,482 | $4,334 | 34.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 43 | 49 | $11,802 | $3,489 | 29.6% |
About Dr. Erika Summers, MD
Dr. Erika Summers, MD is a Dermatology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386826006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erika Summers, MD has received a total of $1,073 in payments from pharmaceutical and medical device companies, with $14.51 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Honoraria" ($1,000).
As a Medicare-enrolled provider, Summers has provided services to 1,073 Medicare beneficiaries, totaling 1,900 services with total Medicare billing of $75,568. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Salt Lake City, UT
- Active Since 12/04/2007
- Last Updated 11/23/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386826006
Products in Payments
- RINVOQ (Biological) $14.51
- XEOMIN (Biological) $11.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Salt Lake City
Dr. Kristina Duffin, M.d, M.D
Dermatology — Payments: $222,787
Mr. Mark Taylor, Md, MD
Dermatology — Payments: $67,995
Dr. Gerald Gleich, M.d, M.D
Dermatology — Payments: $53,083
Dr. Stephanie Zone, Md, MD
Dermatology — Payments: $15,276
Dr. Keith Duffy, M.d, M.D
Dermatology — Payments: $10,223
Lauren Madigan
Dermatology — Payments: $5,705